Transgene

About Transgene

Transgene is a biotechnology company focused on designing and developing innovative immunotherapies to fight cancer. Their mission is to create groundbreaking treatments by leveraging advanced technologies and engineering viral genomes.

Products & Services

TG4050:An individualized immunotherapy from the myvac platform, utilizing advanced genetic engineering and AI. Currently in a randomized Phase I/II trial.

TG4001:A therapeutic vaccine targeting shared antigens for cancer treatment.

BT-001:An armed oncolytic virus designed to modulate the tumor microenvironment and attack tumors directly.

myvac Platform:A technology platform for creating individualized therapeutic vaccines.

Invir.IO Platform:A platform for developing next-generation oncolytic viruses that target tumors and modulate their microenvironment.

Specialties

Immunotherapy Cancer Treatment Viral Genome Engineering Oncolytic Viruses Therapeutic Vaccines Artificial Intelligence in Drug Development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Sale of Securities T: - FT: Sale of Securities	A: 15300000 MR: - FA: 15.3 million FAN: 15300000	D: 2023-07-17 FD: 2023-07-17	-

Sale of Securities Latest

2023-07-17

$15.3M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Alessandro Riva

Chief Executive Officer

C

Christophe Ancel

Director of Pharmaceutical Operations and Responsible Pharmacist

LinkedIn (Pro only)

M

Maurizio Ceppi

Chief Scientific Officer

E

Emmanuelle Dochy

Chief Medical Officer

J

John Felitti

General Secretary and Legal Director

L

Lucie Larguier

Chief Financial Officer (CFO)

View 41 more team members with Pro

Unlock Full Team Directory

Recent News

Transgene Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised